$5.29
-0.05 (-0.94%)
Open$5.40
Previous Close$5.34
Day High$5.44
Day Low$5.16
52W High$12.70
52W Low$5.90
Volume—
Avg Volume15.3K
Market Cap1.92M
P/E Ratio—
EPS$-4.96
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+83.7% upside
Current
$5.29
$5.29
Target
$9.72
$9.72
$6.32
$9.72 avg
$10.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 493.3K | 481.3K | 473.6K |
| Net Income | 115.4K | 80.6K | 101.2K |
| Profit Margin | 23.4% | 16.8% | 21.4% |
| EBITDA | 189.6K | 155.0K | 161.9K |
| Free Cash Flow | 102.8K | 100.3K | 125.4K |
| Rev Growth | +17.7% | -1.9% | +10.9% |
| Debt/Equity | 0.11 | 0.15 | 0.11 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |